课题基金 / 基金详情

Bleeding, transfusion, and the use of anticoagulants in patients with critical illness: Generating evidence to inform practice change and improve outcomes

Bleeding, transfusion, and the use of anticoagulants in patients with critical illness: Generating evidence to inform practice change and improve outcomes
危重患者的出血、输血和抗凝剂的使用:生成证据以告知实践改变和改善结果
批准号:
302242
负责人:
Zarychanski Ryan
金额:
$21.86万
依托单位:
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-12-01 至 2018-12-01

项目摘要

项目成果

Zarychanski Ryan的其他基金

相似基金

相关文献

中文摘要
翻译
与不需要输血的患者相比,出血和输血血液制品与不良事件和不良结局相关。血液也是一种稀缺的捐赠资源,必须加以保护。在严重出血的重症患者中,
英文摘要
Bleeding and transfusion of blood products are associated with adverse events and poor outcomes compared to those who do not require blood. Blood is also a scare donor resource that must be preserved. In critically ill patients who are severely bleeding,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)
  • 批准号:
    463407
  • 项目类别:
    Operating Grants
  • 资助金额:
    $288.63万
  • 财政年份:
    2022
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
ANTI-THROMBOTIC THERAPY TO AMELIORATE COMPLICATIONS OF COVID-19 (ATTACC): A randomized, international, multi-centre, adaptive, controlled clinical trial
  • 批准号:
    429655
  • 项目类别:
    Operating Grants
  • 资助金额:
    $260.32万
  • 财政年份:
    2020
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
  • 批准号:
    405787
  • 项目类别:
    Operating Grants
  • 资助金额:
    $174.34万
  • 财政年份:
    2019
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
Tranexamic acid to reduce red blood cell transfusion in major non-cardiac surgery (TRACTION): A pragmatic, registry-based, pilot, randomized controlled trial
  • 批准号:
    398808
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2018
  • 负责人:
    Zarychanski Ryan
  • 依托单位:
海外基金